ici 118551 and h 89

ici 118551 has been researched along with h 89 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coash, M; Ferro, A; Ji, Y; Queen, L; Rob, J; Yamamoto, T1
Chartier, D; Ehrlich, JR; Hébert, TE; Nattel, S; Qi, X; Yeh, YH1
Anastasio, A; Del Giudice, C; Iaccarino, G; Santulli, G; Sorriento, D; Trimarco, B1
Goshima, H; Ishizuka, T; Ozawa, A; Watanabe, Y1

Other Studies

4 other study(ies) available for ici 118551 and h 89

ArticleYear
Nitric oxide-dependent beta2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt.
    British journal of pharmacology, 2004, Volume: 143, Issue:3

    Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Androstadienes; Animals; Aorta, Thoracic; Blotting, Western; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; In Vitro Techniques; Isoproterenol; Isoquinolines; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phenylephrine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Propanolamines; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2; Sulfonamides; Vasodilation; Wortmannin

2004
Adrenergic control of a constitutively active acetylcholine-regulated potassium current in canine atrial cardiomyocytes.
    Cardiovascular research, 2007, Jun-01, Volume: 74, Issue:3

    Topics: Acetylcholine; Action Potentials; Adrenergic Agents; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Bee Venoms; Clonidine; Cyclic AMP-Dependent Protein Kinases; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Estrenes; Heart Atria; Imidazoles; Indoles; Isoproterenol; Isoquinolines; Maleimides; Myocytes, Cardiac; Patch-Clamp Techniques; Phenylephrine; Phorbol 12,13-Dibutyrate; Piperazines; Potassium Channels; Prazosin; Propanolamines; Propranolol; Protein Kinase C; Pyrrolidinones; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-1; Sulfonamides; Type C Phospholipases

2007
Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo.
    Hypertension (Dallas, Tex. : 1979), 2012, Volume: 60, Issue:1

    Topics: Adrenergic beta-Antagonists; Animals; Blotting, Western; Catecholamines; Cattle; Cell Hypoxia; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Dopa Decarboxylase; Dopamine beta-Hydroxylase; Endothelial Cells; Endothelium, Vascular; Femoral Artery; Hindlimb; Immunohistochemistry; Ischemia; Isoquinolines; Mice; Mice, Inbred C57BL; Propanolamines; Receptors, Adrenergic, beta-2; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sulfonamides; Tyrosine 3-Monooxygenase

2012
Involvement of β-adrenoceptors in the differentiation of human induced pluripotent stem cells into mesodermal progenitor cells.
    European journal of pharmacology, 2014, Oct-05, Volume: 740

    Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Atenolol; Cell Differentiation; Cell Line; Cyclic AMP-Dependent Protein Kinases; Humans; Imidazoles; Induced Pluripotent Stem Cells; Isoproterenol; Isoquinolines; p38 Mitogen-Activated Protein Kinases; Propanolamines; Protein Kinase Inhibitors; Pyridines; Receptors, Adrenergic, beta; Sulfonamides; Vascular Endothelial Growth Factor Receptor-2

2014